Search
Eupraxia Pharmaceuticals Inc
EPRXAdd to Watchlist
7.590USD
-0.140-1.81%
Close 10-22 16:00（ET）
493.50MMarket Cap
LossP/E TTM
Eupraxia Pharmaceuticals Inc (EPRX) Stock Price Target & Forecast
Analyst Rating
Based on 10 analysts giving stock ratings to Eupraxia Pharmaceuticals Inc in the past month.
Buy
4 Strong Buy
6 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
16.778USD+153.44%
EPRX Analyst Recommendation Trends
In the current month, EPRX has received 6 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. EPRX average Analyst price target in the last month is 16.778.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
4
4
3
3
2
1
1
1
6
6
6
6
6
6
6
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10
10
9
9
8
7
7
7
Financial Forecasting
Based on analysts' estimates, EPRX EPS is projected to reach -0.250 in FY2026Q3, following reported EPS of -0.219 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.16
-0.19
-0.25
-0.25
-0.26
Actual
-0.33
-0.22
-0.22
--
--
Surprise
-105.75%
-15.40%
+11.31%
--
--
FAQs
What is Eupraxia Pharmaceuticals Inc's price target?
Analysts forecast that Eupraxia Pharmaceuticals Inc's price target is USD 12.00, with the highest forecast at USD 14.00 and the lowest forecast at USD 11.00.
How have Eupraxia Pharmaceuticals IncEPRX's recent earnings per share performed?
The market expectation was USD -0.22, while Eupraxia Pharmaceuticals IncEPRX's earnings per share (EPS) for the previous quarter was USD -0.22. EPS for the next quarter is expected at USD -0.25.
What is the analyst rating for Eupraxia Pharmaceuticals Inc?
Based on the ratings of Eupraxia Pharmaceuticals Inc's stock from 10 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.